Monocyte chemotactic protein-1 and nitrotyrosine in irritable bowel syndrome

Experimental and Therapeutic Medicine
Alexandra ChiraDan Lucian Dumitrascu

Abstract

Irritable bowel syndrome (IBS) is one the most frequent and common functional gastrointestinal disorders that has a multifactorial etiopathogenesis. Multiple biomarkers have been tested in search for a reliable and specific biomarker, but there is not yet a specific biomarker for IBS. The aim of this study was to evaluate two biomarkers of different putative pathways of the pathogenesis of IBS: the monocyte chemotactic protein-1 (MCP-1) and nitrotyrosine, in order to establish their role as potential biomarkers. We enrolled 42 consecutive IBS patients diagnosed by Rome III criteria and 35 consecutive healthy controls. Serum concentrations for the two biomarkers (MCP-1 and nitrotyrosine) were determined using commercial ELISA kits. Serum levels of MCP-1 were not statistically significantly higher in IBS patients than in controls (204±130 vs. 174±73 pg/ml; P=0.311). Nitrotyrosine levels were statistically significantly lower in IBS patients than in controls (30±12 vs. 353±14 nM; P=0.050). MCP-1 levels were higher in IBS patients with metabolic syndrome versus IBS patients without metabolic syndrome (239±153 vs. 168±120 pg/ml; P=0.948) and in controls with metabolic syndrome (174±56 pg/ml). MCP-1 serum levels were statistically si...Continue Reading

References

Mar 1, 1996·The Journal of Infection·M W McKendrick
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·V GoedeH G Augustin
Aug 3, 1999·Alimentary Pharmacology & Therapeutics·D A Drossman
Nov 5, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·H InaderaK Matsushima
Sep 13, 2000·Gastroenterology·I M GralnekE A Mayer
May 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Peter Sartipy, David J Loskutoff
May 3, 2005·Gastroenterology Clinics of North America·George F Longstreth
Nov 2, 2005·Journal of Health and Social Behavior·Deborah Carr, Michael A Friedman
Aug 31, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edy StermerAlexandra Lavy
May 6, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Susan J ShepherdPeter R Gibson
Feb 20, 2009·Alimentary Pharmacology & Therapeutics·A J LemboH Pan
Jul 16, 2011·PloS One·Zhonghao YuRui Wang-Sattler
Mar 1, 2012·Deutsches Ärzteblatt International·Winfried HäuserWolfgang Kruis
Oct 26, 2012·The New England Journal of Medicine·Michael Camilleri
Sep 14, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Rafet MeteAhmet Gurel
Oct 3, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Arsen ArakelyanAnna Boyajyan
Aug 6, 2014·The American Journal of Gastroenterology·Alexander C FordEamonn M M Quigley
Aug 30, 2014·World Journal of Gastroenterology : WJG·Ling LanGuo-Dong Xia
Nov 5, 2014·Genetics and Molecular Research : GMR·Z ZhaoH N Xie
Jun 4, 2015·São Paulo Medical Journal = Revista Paulista De Medicina·Liliana-Elisabeta DavidDan-Lucian Dumitrascu
Nov 7, 2016·Journal of Neurogastroenterology and Motility·Jae Hak KimMark Pimentel
Aug 30, 2017·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M BashashatiG Barbara

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Gastroenterology & Hepatology
Isobel Franks
Clinics and Research in Hepatology and Gastroenterology
Seyedmehdi SeyedmirzaeeMojgan Mohammadi
American Journal of Obstetrics and Gynecology
Rachel E WilliamsJohn F Steege
Clinical Epidemiology
Caroline CanavanTimothy Card
© 2022 Meta ULC. All rights reserved